Income Statement Xinxiang Chemical Fiber Co., Ltd.
Equities
000949
CNE0000010N4
Textiles & Leather Goods
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.340 CNY | -4.57% | -12.34% | +3.41% |
Aug. 15 | Xinxiang Chemical Fiber Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Jul. 08 | Xinxiang Chemical Fiber Co., Ltd. announced a financing transaction | CI |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 4.65B | 4.31B | 8.57B | 6.82B | 7.12B | |||||
Other Revenues, Total | 159M | 163M | 173M | 457M | 256M | |||||
Total Revenues | 4.8B | 4.48B | 8.74B | 7.27B | 7.38B | |||||
Cost of Goods Sold, Total | 4.12B | 3.74B | 5.95B | 7.12B | 6.84B | |||||
Gross Profit | 679M | 734M | 2.79B | 155M | 535M | |||||
Selling General & Admin Expenses, Total | 328M | 257M | 379M | 485M | 220M | |||||
Provision for Bad Debts | 10.96M | 4.73M | -6.41M | 3.64M | 16.12M | |||||
R&D Expenses | 12.26M | 96.65M | 128M | 190M | 104M | |||||
Other Operating Expenses | 41.82M | 61.73M | 128M | 57.17M | 67.97M | |||||
Other Operating Expenses, Total | 393M | 420M | 629M | 736M | 408M | |||||
Operating Income | 286M | 314M | 2.16B | -581M | 127M | |||||
Interest Expense, Total | -130M | -153M | -159M | -138M | -139M | |||||
Interest And Investment Income | 6.05M | 3.12M | 7.81M | 25.92M | 15.32M | |||||
Net Interest Expenses | -124M | -150M | -151M | -112M | -123M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | 7.58M | -38.27M | -33.41M | 94.04M | 7.8M | |||||
Other Non Operating Income (Expenses) | -6.61M | -4.15M | -7.14M | -42.33M | -6.31M | |||||
EBT, Excl. Unusual Items | 163M | 121M | 1.97B | -642M | 5.32M | |||||
Gain (Loss) On Sale Of Investments | -594K | -11.59M | -5.82M | 26.92K | -8.6M | |||||
Gain (Loss) On Sale Of Assets | -1.89M | -6.43M | -808 | 1.78K | - | |||||
Asset Writedown | -5.24M | -31.91M | -127M | -4.62M | -8.21M | |||||
Insurance Settlements | - | - | - | - | - | |||||
Other Unusual Items | 16.89M | 37.15M | -44.75M | 26.48M | 27.16M | |||||
EBT, Incl. Unusual Items | 173M | 109M | 1.79B | -620M | 15.67M | |||||
Income Tax Expense | 42.72M | 25.1M | 425M | -185M | 57.82M | |||||
Earnings From Continuing Operations | 130M | 83.57M | 1.37B | -435M | -42.15M | |||||
Net Income to Company | 130M | 83.57M | 1.37B | -435M | -42.15M | |||||
Minority Interest | -235K | 13.82K | 111K | 70.4K | - | |||||
Net Income - (IS) | 130M | 83.59M | 1.37B | -435M | -42.15M | |||||
Net Income to Common Incl Extra Items | 130M | 83.59M | 1.37B | -435M | -42.15M | |||||
Net Income to Common Excl. Extra Items | 130M | 83.59M | 1.37B | -435M | -42.15M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.1 | 0.07 | 1 | -0.3 | -0.03 | |||||
Basic EPS - Continuing Operations | 0.1 | 0.07 | 1 | -0.3 | -0.03 | |||||
Basic Weighted Average Shares Outstanding | 1.26B | 1.26B | 1.36B | 1.47B | 1.42B | |||||
Net EPS - Diluted | 0.1 | 0.07 | 1 | -0.3 | -0.03 | |||||
Diluted EPS - Continuing Operations | 0.1 | 0.07 | 1 | -0.3 | -0.03 | |||||
Diluted Weighted Average Shares Outstanding | 1.26B | 1.26B | 1.36B | 1.47B | 1.42B | |||||
Normalized Basic EPS | 0.08 | 0.06 | 0.9 | -0.27 | 0 | |||||
Normalized Diluted EPS | 0.08 | 0.06 | 0.9 | -0.27 | 0 | |||||
Dividend Per Share | 0.01 | 0.01 | 0.1 | - | - | |||||
Payout Ratio | 125.5 | 208.32 | 12.71 | -68.55 | -368.76 | |||||
Supplemental Items | ||||||||||
EBITDA | 716M | 761M | 2.75B | 157M | 888M | |||||
EBITA | 288M | 316M | 2.16B | -577M | 134M | |||||
EBIT | 286M | 314M | 2.16B | -581M | 127M | |||||
EBITDAR | 722M | 767M | 2.75B | 161M | 895M | |||||
Total Revenues (As Reported) | 4.8B | 4.48B | 8.74B | 7.27B | 7.38B | |||||
Effective Tax Rate - (Ratio) | 24.76 | 23.1 | 23.76 | 29.86 | 369.07 | |||||
Total Current Taxes | 24.71M | -830K | 449M | -4.06M | 89.61K | |||||
Total Deferred Taxes | 18.02M | 25.93M | -23.86M | -181M | 57.73M | |||||
Normalized Net Income | 102M | 75.93M | 1.23B | -401M | 3.33M | |||||
Interest Capitalized | 22.66M | 8.1M | 607K | 14.7M | 18.01M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 965K | 513K | 575K | 432K | 583K | |||||
Marketing Expenses | 341K | - | - | - | - | |||||
Selling and Marketing Expenses | 103M | 33.92M | 37.19M | 32.52M | 33.36M | |||||
General and Administrative Expenses | 221M | 219M | 342M | 452M | 187M | |||||
Research And Development Expense From Footnotes | 99.92M | 96.65M | 128M | 190M | 104M | |||||
Net Rental Expense, Total | 5.35M | 6.22M | 3.43M | 4.14M | 6.82M | |||||
Imputed Operating Lease Interest Expense | 2.07M | 2.15M | 1.14M | 1.3M | 1.99M | |||||
Imputed Operating Lease Depreciation | 3.27M | 4.06M | 2.29M | 2.84M | 4.84M | |||||
Maintenance & Repair Expenses, Total | 35.74M | 44.98M | 89.84M | 136M | 14.63M |